| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47978-0.1mg | |||
| IHC-Prediluted | NBP2-48076 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-82249-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-18558-25ul | |||
| Azide and BSA Free | NBP3-44374 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-18580-25ul | |||
| Azide and BSA Free | NBP3-44377 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-87191-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-89818-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21205-25ul | |||
| Azide and BSA Free | NBP3-44327 | |||
![Immunohistochemistry-Paraffin: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NB100-81960. The picture on the right is blocked with the phospho peptide.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241446224.jpg "Immunohistochemistry-Paraffin: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Immunohistochemical analysis of paraffin-embedded human breast carcinoma, using NB100-81960. The picture on the right is blocked with the phospho peptide.")
![Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Western Blot analysis of 293 cells using NB100-81960 diluted at 1: 1000](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241545355.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Western blot analysis of lysates from HepG2 cells treated with PMA 125ng/ml 30', using NB100-81960. The lane on the right is blocked with the phospho peptide.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-23420241545357.jpg)
![Immunocytochemistry/ Immunofluorescence: ErbB2/Her2 [p Tyr1248] Antibody [NB100-81960] - Mutant ERBB2 cooperates with loss of p53 & leads to papillary GBC in recipient mice. (A) Top: Schematic of human ERBB2, indicating the location of two point mutants (S310F & V777L). Bottom: retroviral vector used to transduce organoids, that had been treated with an sgp53-containing plasmid (px459) to induce loss of p53. (B) Immunofluorescence for ERBB2 (top) & phospho-ERBB2 (bottom) on organoids harboring the indicated genetic alterations. (C) Tumor volumes 36 days after s.c. implantation of the respective organoids into recipient mice. All mice transplanted with sgp53;ERBB2S310F- & sgp53;ERBB2V777L organoids exhibited tumor development, whereas sgp53;empty vector- & sgp53;ERBB2wildtype organoids did not give rise to tumors over a four-month observation period. There was no significant difference in the tumor burden of mice transplanted with sgp53;ERBB2S310F- & sgp53;ERBB2V777L organoids (p = 0.999). (D) Mice transplanted with sgp53;ERBB2S310F- & sgp53;ERBB2V777L organoids reached endpoint criteria with a median survival of 79.5 days & 58.5 days, respectively. (E) H&E & IHC for CK19 & EGFP on tumors generated with sgp53;ERBB2S310- & sgp53;ERBB2V777L organoids. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31795490), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nb100-81960_rabbit-polyclonal-erbb2-her2-p-tyr1248-antibody-310202416284926.jpg)
![Western Blot: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - HCT116 cell lysate using Cytokeratin 18 Mouse Monoclonal Antibody (Cocktail). Image using the Azide and BSA Free format of this antibody.](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Western-Blot-NBP2-44907-img0007.jpg "Western Blot: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - HCT116 cell lysate using Cytokeratin 18 Mouse Monoclonal Antibody (Cocktail). Image using the Azide and BSA Free format of this antibody.")
![Immunohistochemistry-Paraffin: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - Human Prostate Carcinoma stained with Cytokeratin 18 Monoclonal Antibody (Cocktail).](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Immunohistochemistry-Paraffin-NBP2-44907-img0004.jpg)
![Flow Cytometry: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - Flow Cytometric Analysis of PFA-fixed HeLa cells using Cytokeratin 18 Antibody (Cocktail) followed by Goat anti-Mouse IgG-CF488 (Blue); Isotype Control (Red)](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Flow-Cytometry-NBP2-44907-img0006.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - Human Cervical Carcinoma stained with Cytokeratin 18 Monoclonal Antibody (Cocktail).](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Immunohistochemistry-Paraffin-NBP2-44907-img0001.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - Human Colon Carcinoma stained with Cytokeratin 18 Monoclonal Antibody (Cocktail).](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Immunohistochemistry-Paraffin-NBP2-44907-img0002.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - Human Lung Carcinoma stained with Cytokeratin 18 Monoclonal Antibody (Cocktail).](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Immunohistochemistry-Paraffin-NBP2-44907-img0003.jpg)
![Immunohistochemistry-Paraffin: Cytokeratin 18 Antibody (Cocktail) [NBP2-44907] - Human Thyroid Carcinoma stained with Cytokeratin 18 Monoclonal Antibody (Cocktail).](http://images.novusbio.com/fullsize/Cytokeratin-18-Antibody-Cocktail-Immunohistochemistry-Paraffin-NBP2-44907-img0005.jpg)
![Western Blot: PTS Antibody [NBP1-32975] - Wild-type (WT) and PTS knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with PTS antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/PTS-Antibody-Western-Blot-NBP1-32975-img0006.jpg "<b>Genetic Strategies Validation. </b>Western Blot: PTS Antibody [NBP1-32975] - Wild-type (WT) and PTS knockout (KO) HeLa cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with PTS antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: PTS Antibody [NBP1-32975] - Analysis of methanol-fixed HeLa, using antibody at 1:100 dilution.](http://images.novusbio.com/fullsize/PTS-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-32975-img0002.jpg)
![Immunohistochemistry-Paraffin: PTS Antibody [NBP1-32975] - Paraffin-embedded Hepatoma, using antibody at 1:500 dilution.](http://images.novusbio.com/fullsize/PTS-Antibody-Immunohistochemistry-Paraffin-NBP1-32975-img0003.jpg)
![Western Blot: PTS Antibody [NBP1-32975] - Sample (30 ug of whole cell lysate) A: H1299 15% SDS PAGE diluted at 1:1000](http://images.novusbio.com/fullsize/PTS-Antibody-Western-Blot-NBP1-32975-img0001.jpg)
![Western Blot: PTS Antibody [NBP1-32975] - Sample (50 ug of whole cell lysate) A: mouse stomach 15% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/PTS-Antibody-Western-Blot-NBP1-32975-img0004.jpg)
![Western Blot: PTS Antibody [NBP1-32975] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 15% SDS-PAGE, and the membrane was blotted with PTS antibody diluted at 1:5000. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.](http://images.novusbio.com/fullsize/PTS-Antibody-Western-Blot-NBP1-32975-img0005.jpg)
![Western Blot: BRCA1 [p Ser1423] Antibody [NB100-226] - Detection of Human Phospho BRCA1 (S1423) by Western Blot. Samples : Whole cell lysate (50 ug) from HeLa cells treated with 100 uM EPE for 4 hours (+) or mock treated (-) cells. Antibody: Affinity purified rabbit anti-Phospho BRCA1 (S1423) antibody NB100-226 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](http://images.novusbio.com/fullsize/BRCA1-[p-Ser1423]-Antibody-Western-Blot-NB100-226-img0004.jpg "<b>Biological Strategies Validation. </b>Western Blot: BRCA1 [p Ser1423] Antibody [NB100-226] - Detection of Human Phospho BRCA1 (S1423) by Western Blot. Samples : Whole cell lysate (50 ug) from HeLa cells treated with 100 uM EPE for 4 hours (+) or mock treated (-) cells. Antibody: Affinity purified rabbit anti-Phospho BRCA1 (S1423) antibody NB100-226 used for WB at 0.1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.")
![<b>Biological Strategies Validation. </b>Western Blot: BRCA1 [p Ser1423] Antibody [NB100-226] - Detection of Brca1 phospho Ser 1423 by Western blot using NB 100-226. Sample whole cell lysate (25 mcg/lane) from HeLa cells treated with 10 Gy IR or untreated. NB 100-226 was used at 1:2500 dilution.](http://images.novusbio.com/fullsize/BRCA1-[p-Ser1423]-Antibody-Western-Blot-NB100-226-img0002.jpg)
![Western Blot: Tau [p Thr231] Antibody [NB100-82249] - Western blot analysis of extracts from mouse brain tissue using NB100-82249 and the same antibody preincubated with blocking peptide.](http://images.novusbio.com/fullsize/Tau-[p-Thr231]-Antibody-Western-Blot-NB100-82249-img0002.jpg "Western Blot: Tau [p Thr231] Antibody [NB100-82249] - Western blot analysis of extracts from mouse brain tissue using NB100-82249 and the same antibody preincubated with blocking peptide.")
![Immunohistochemistry: Tau [p Thr231] Antibody [NB100-82249] - Immunohistochemical analysis of paraffin-embedded rat hippocampal region tissue from a model with Alzheimer's Disease using Tau (phospho-Thr231) antibody.](http://images.novusbio.com/fullsize/Tau-[p-Thr231]-Antibody-Immunohistochemistry-NB100-82249-img0001.jpg)
![Western Blot: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - JAM2 monoclonal antibody (M01), clone 1G4. Analysis of JAM2 expression in human ovarian cancer.](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-Western-Blot-H00058494-M01-img0013.jpg "Western Blot: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - JAM2 monoclonal antibody (M01), clone 1G4. Analysis of JAM2 expression in human ovarian cancer.")
![Immunohistochemistry-Paraffin: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - Analysis of monoclonal antibody to JAM2 on formalin-fixed paraffin-embedded human malignant lymphoma, diffuse large B tissue. Antibody concentration 1 ug/ml.](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-Immunohistochemistry-Paraffin-H00058494-M01-img0010.jpg)
![Western Blot: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - JAM2 expression in LNCaP ( Cat # L004V1 ).](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-Western-Blot-H00058494-M01-img0008.jpg)
![Western Blot: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - JAM2 monoclonal antibody (M01), clone 1G4. Analysis of JAM2 expression in HL-60.](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-Western-Blot-H00058494-M01-img0012.jpg)
![Western Blot: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - Analysis of JAM2 expression in transfected 293T cell line by JAM2 monoclonal antibody (M01), clone 1G4.Lane 1: JAM2 transfected lysate (Predicted MW: 33.2 KDa).Lane 2: Non-transfected lysate.](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-Western-Blot-H00058494-M01-img0014.jpg)
![ELISA: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - Detection limit for recombinant GST tagged JAM2 is approximately 3ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-ELISA-H00058494-M01-img0005.jpg)
![Sandwich ELISA: JAM-B/VE-JAM Antibody (1G4) [H00058494-M01] - Detection limit for recombinant GST tagged JAM2 is approximately 0.1ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/JAM-B-VE-JAM-Antibody-1G4-Sandwich-ELISA-H00058494-M01-img0011.jpg)
![Western Blot: CD44 Antibody (CL13328) [NBP3-18558] - Analysis in human cell line U-251 MG and human cell line MCF-7.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Western-Blot-NBP3-18558-img0009.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: CD44 Antibody (CL13328) [NBP3-18558] - Analysis in human cell line U-251 MG and human cell line MCF-7.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0008.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Analysis in human cervix, uterine and skeletal muscle tissues using NBP3-18558 antibody. Corresponding CD44 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0001.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human malignant melanoma shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0002.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human ovarian cancer (low grade carcinoma) shows strong membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0003.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human breast cancer (metastasis to ovary) shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0004.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human uterine cervix shows strong membranous positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0005.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human lymph node shows strong membranous positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0006.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13328) [NBP3-18558] - Staining of human colon shows strong membranous positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13328-Immunohistochemistry-Paraffin-NBP3-18558-img0007.jpg)
![Western Blot: CD44 Antibody (CL13318) [NBP3-18580] - Analysis in human cell line U-251 MG and human cell line MCF-7.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Western-Blot-NBP3-18580-img0009.jpg "<b>Orthogonal Strategies Validation. </b>Western Blot: CD44 Antibody (CL13318) [NBP3-18580] - Analysis in human cell line U-251 MG and human cell line MCF-7.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human skeletal muscle shows no positivity in myocytes as expected.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0008.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Analysis in human cervix, uterine and skeletal muscle tissues using NBP3-18580 antibody. Corresponding CD44 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0001.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human endometrial cancer shows strong membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0002.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human breast cancer (metastasis to ovary) shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0003.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human malignant melanoma shows moderate membranous positivity in tumor cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0004.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human lymph node shows strong membranous positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0005.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human uterine cervix shows moderate membranous positivity in squamous epithelial cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0006.jpg)
![Immunohistochemistry-Paraffin: CD44 Antibody (CL13318) [NBP3-18580] - Staining of human colon shows strong membranous positivity in lymphoid cells.](http://images.novusbio.com/fullsize/CD44-Antibody-CL13318-Immunohistochemistry-Paraffin-NBP3-18580-img0007.jpg)
![Western Blot: PTP1B/PTPN1 Antibody [NBP1-87191] - Analysis in U-138MG cells transfected with control siRNA, target specific siRNA probe #1 and #2, using Anti-PTPN1 antibody. Remaining relative intensity is presented. Loading control: Anti-PPIB.](http://images.novusbio.com/fullsize/PTP1B-PTPN1-Antibody-Western-Blot-NBP1-87191-img0007.jpg "<b>Genetic Strategies Validation. </b>Western Blot: PTP1B/PTPN1 Antibody [NBP1-87191] - Analysis in U-138MG cells transfected with control siRNA, target specific siRNA probe #1 and #2, using Anti-PTPN1 antibody. Remaining relative intensity is presented. Loading control: Anti-PPIB.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: PTP1B/PTPN1 Antibody [NBP1-87191] - Staining of human cell line U-2 OS shows positivity in endoplasmic reticulum.](http://images.novusbio.com/fullsize/PTP1B-PTPN1-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-87191-img0004.jpg)
![Immunohistochemistry-Paraffin: PTP1B/PTPN1 Antibody [NBP1-87191] - Staining of human placenta shows strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/PTP1B-PTPN1-Antibody-Immunohistochemistry-Paraffin-NBP1-87191-img0011.jpg)
![Immunohistochemistry-Paraffin: PTP1B/PTPN1 Antibody [NBP1-87191] - Staining of human duodenum shows moderate cytoplasmic positivity in glandular cells.](http://images.novusbio.com/fullsize/PTP1B-PTPN1-Antibody-Immunohistochemistry-Paraffin-NBP1-87191-img0008.jpg)
![Immunohistochemistry-Paraffin: PTP1B/PTPN1 Antibody [NBP1-87191] - Staining of human lung shows moderate cytoplasmic positivity in macrophages.](http://images.novusbio.com/fullsize/PTP1B-PTPN1-Antibody-Immunohistochemistry-Paraffin-NBP1-87191-img0009.jpg)
![Immunohistochemistry-Paraffin: PTP1B/PTPN1 Antibody [NBP1-87191] - Staining of human lymph node shows moderate to strong cytoplasmic positivity in non-germinal center cells.](http://images.novusbio.com/fullsize/PTP1B-PTPN1-Antibody-Immunohistochemistry-Paraffin-NBP1-87191-img0010.jpg)
![Western Blot: PKC alpha Antibody [NBP1-87269] - Analysis using Anti-PRKCA antibody NBP1-87269 (A) shows similar pattern to independent antibody NBP1-87268 (B).](http://images.novusbio.com/fullsize/PKC-alpha-Antibody-Western-Blot-NBP1-87269-img0014.jpg "<b>Independent Antibodies Validation. </b>Western Blot: PKC alpha Antibody [NBP1-87269] - Analysis using Anti-PRKCA antibody NBP1-87269 (A) shows similar pattern to independent antibody NBP1-87268 (B).")
![<b>Independent Antibodies Validation. </b>Immunocytochemistry/Immunofluorescence: PKC alpha Antibody [NBP1-87269] - Staining of human cell line U-2 OS shows localization to plasma membrane and cytosol.](http://images.novusbio.com/fullsize/PKC-alpha-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-87269-img0012.jpg)
![Immunohistochemistry-Paraffin: PKC alpha Antibody [NBP1-87269] - Staining of human cerebral cortex shows moderate cytoplasmic positivity in neuronal cells.](http://images.novusbio.com/fullsize/PKC-alpha-Antibody-Immunohistochemistry-Paraffin-NBP1-87269-img0011.jpg)
![Western Blot: PKC alpha Antibody [NBP1-87269] - Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells). Lane 2: NBT-II cell lysate (Rat Wistar bladder tumor cells).](http://images.novusbio.com/fullsize/PKC-alpha-Antibody-Western-Blot-NBP1-87269-img0004.jpg)
![Western Blot: PKC alpha Antibody [NBP1-87269] - Lane 1: Marker {kDA] 250, 130, 100, 70, 55, 35, 25, 15, 10. Lane 2: Huan Cerebral Cortex tissue.](http://images.novusbio.com/fullsize/PKC-alpha-Antibody-Western-Blot-NBP1-87269-img0008.jpg)
![<b>Orthogonal Strategies Validation. </b>Western Blot: PKC alpha Antibody [NBP1-87269] - Analysis in human cell lines A-549 and Caco-2 using anti-PRKCA antibody. Corresponding PRKCA RNA-seq data are presented for the same cell lines. Loading control: anti-GAPDH.](http://images.novusbio.com/fullsize/PKC-alpha-Antibody-Western-Blot-NBP1-87269-img0013.jpg)
![Immunocytochemistry/Immunofluorescence: Alpha Actinin 4 Antibody [NBP1-89818] - Staining of human cell line A-431 shows localization to nuclear bodies. Antibody staining is shown in green.](http://images.novusbio.com/fullsize/Alpha-Actinin-4-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-89818-img0008.jpg "Immunocytochemistry/Immunofluorescence: Alpha Actinin 4 Antibody [NBP1-89818] - Staining of human cell line A-431 shows localization to nuclear bodies. Antibody staining is shown in green.")
![Immunohistochemistry-Paraffin: Alpha Actinin 4 Antibody [NBP1-89818] - Staining of human liver shows strong cytoplasmic and membranous positivity in bile duct cells.](http://images.novusbio.com/fullsize/Alpha-Actinin-4-Antibody-Immunohistochemistry-Paraffin-NBP1-89818-img0001.jpg)
